HYAL2 and inflammatory bowel disease: Another non-oncological GI disease process, inflammatory bowel disease (IBD), is associated with a reduction in HYAL2 in patients’ platelets, which has been shown to regulate trans-endothelial mononuclear cell migration in colonic tissue of IBD patients [61].